PHARMAXIS
Pharmaxis Ltd (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory disorders. Its product Aridol® forthe assessment of asthma issold in key international markets. Its product Bronchitol® for cystic fibrosis is recently launched in Europe and Australia and its development pipeline of productsincludes, Bronchitol for bronchiectasis, PXS64 forthe treatment of lung fibrosis, ASM8 for asthma and PXS4728 for fibrotic disease. Pharmaxisislisted on the Australian Securities Exchange (symbol PXS). The company’s head office and manufacturing facilities are located in Sydney.
PHARMAXIS
Industry:
Biotechnology Health Care Pharmaceutical Product Research
Founded:
1998-01-01
Address:
New Farm, Queensland, Australia
Country:
Australia
Website Url:
http://www.pharmaxis.com.au
Total Employee:
51+
Status:
Active
Contact:
61 2 9454 7200
Email Addresses:
[email protected]
Total Funding:
1.39 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
LipoSeuticals
Specialty pharmaceutical company.
Palmira Biopharma
Biopharmaceutical company
Renovo Research
Renovo is a pharmaceutical company.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-01-12 | Topigen Pharmaceuticals | Topigen Pharmaceuticals acquired by Pharmaxis | N/A |
Official Site Inspections
http://www.pharmaxis.com.au Semrush global rank: 7.81 M Semrush visits lastest month: 437
Unable to get host informations!!!
